| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/14728222.10.2.203 |
| P698 | PubMed publication ID | 16548770 |
| P2093 | author name string | Basalingappa L Hungund | |
| K Yaragudri Vinod | |||
| P2860 | cites work | Endocannabinoid signalling in the blood of patients with schizophrenia | Q24800061 |
| CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia | Q28206825 | ||
| Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 | ||
| Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Q28262546 | ||
| Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia | Q44748286 | ||
| Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims | Q44765964 | ||
| Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain | Q44785227 | ||
| Differences in basal cannabinoid CB1 receptor function in selective brain areas and vulnerability to voluntary alcohol consumption in Fawn Hooded and Wistar rats. | Q44945320 | ||
| Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms | Q45049153 | ||
| Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress | Q45069054 | ||
| Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress | Q45138851 | ||
| Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear | Q45215137 | ||
| Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents | Q45251047 | ||
| Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims | Q45287377 | ||
| Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors | Q46685295 | ||
| In-vitro and in-vivo action of cannabinoids | Q48109698 | ||
| Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. | Q48183236 | ||
| Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion | Q48285208 | ||
| The functional neuroanatomy of brain cannabinoid receptors | Q48285221 | ||
| Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells | Q48292854 | ||
| Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action | Q48309971 | ||
| Anandamide hydrolysis by human cells in culture and brain | Q48346766 | ||
| Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors | Q48664473 | ||
| Genetic deletion of CB1 receptors improves non-associative learning | Q48880717 | ||
| Involvement of CB1 cannabinoid receptors in emotional behaviour. | Q51055974 | ||
| Anandamide: a candidate neurotransmitter heads for the big leagues. | Q51090766 | ||
| Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. | Q51106735 | ||
| The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. | Q52897872 | ||
| Endocannabinoids | Q55282369 | ||
| Pharmacology of Antidepressants | Q56016664 | ||
| Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Cognitive and emotional influences in anterior cingulate cortex | Q29547440 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
| Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
| Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments | Q33695248 | ||
| The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors | Q33940288 | ||
| Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
| Cannabis as a risk factor for psychosis: systematic review | Q33986870 | ||
| Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors | Q34098397 | ||
| Endocannabinoid signaling in the brain | Q34125520 | ||
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 | ||
| Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects | Q34253509 | ||
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential | Q34418106 | ||
| Cannabis use and psychotic disorders: an update | Q34555939 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Schizophrenia: diverse approaches to a complex disease | Q34614652 | ||
| The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions | Q35045001 | ||
| Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes | Q35592076 | ||
| The etiopathogenesis of schizophrenias | Q35951559 | ||
| Role of endogenous cannabinoids in cognition and emotionality | Q36198923 | ||
| Pharmacology of cannabinoid receptors | Q40437020 | ||
| Search for endogenous ligands of the cannabinoid receptor | Q40643774 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 | ||
| Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice | Q42615187 | ||
| The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. | Q42686860 | ||
| The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase | Q43512138 | ||
| Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. | Q43581230 | ||
| Cannabis induced dopamine release: an in-vivo SPECT study | Q43744306 | ||
| Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 | ||
| Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels | Q43890403 | ||
| Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. | Q43975380 | ||
| The endogenous cannabinoid system controls extinction of aversive memories | Q44085607 | ||
| Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex | Q44127906 | ||
| Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens | Q44299680 | ||
| Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats | Q44352771 | ||
| 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. | Q44386848 | ||
| Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. | Q44392539 | ||
| Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. | Q44697078 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 203-210 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders | |
| P478 | volume | 10 |
| Q40647052 | Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects. |
| Q30471167 | Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. |
| Q92497963 | Bipolar disorder and the endocannabinoid system |
| Q47647272 | Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling |
| Q37734568 | Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. |
| Q43202780 | Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis |
| Q38877058 | Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study. |
| Q34609936 | Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression |
| Q37153885 | Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice |
| Q48099573 | In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans |
| Q35103644 | Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats |
| Q46943485 | Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol |
| Q92547045 | Mitochondrial transport serves as a mitochondrial quality control strategy in axons: Implications for central nervous system disorders |
| Q41333517 | No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia |
| Q36162168 | Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence |
| Q37386356 | Resilience to meet the challenge of addiction: psychobiology and clinical considerations |
| Q30465425 | Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population |
| Q36898681 | The pipeline and future of drug development in schizophrenia. |
Search more.